Procalcitonin and acute coronary syndromes: A new biomarker for an old disease

Internal and Emergency Medicine

Volumn 4, Issue 5, 2009, Pages 363-365

  Biasucci, Luigi M ^a   Biasillo, Gina ^a   Stefanelli, Antonella ^a  

^a CATHOLIC UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; CALCITONIN; PROCALCITONIN; PROTEIN PRECURSOR;

ACUTE CORONARY SYNDROME; BLOOD; HUMAN; NOTE;

ACUTE CORONARY SYNDROME; BIOLOGICAL MARKERS; CALCITONIN; HUMANS; PROTEIN PRECURSORS;

EID: 71549150277     PISSN: 18280447     EISSN: 19709366     Source Type: Journal    
DOI: 10.1007/s11739-009-0295-7     Document Type: Note

References (16)

1. Assicot M, Gendrel D, Carsin H, Raymond J, Guilbaud J, Bohuon C (1993) High serum procalcitonin concentrations in patients with sepsis and infection. Lancet 341: 515-518.
2. Oberhoffer M, Stonans I, Russwurm S, Stonane E, Vogelsang H, Junker U, Jäger L, Reinhart K (1999) Procalcitonin expression in human peripheral blood mononuclear cells and its modulation by lipopolysaccharides and sepsis-related cytokines in vitro. J Lab Clin Med 134: 49-55.
3. Dandona P, Nix D, Wilson MF et al (1994) Procalcitonin increase after endotoxin injection in normal subjects. J Clin Endocrinol Metab 79: 1605-1608.
4. Rau B, Steinbach G, Gansauge F et al (1997) The potential role of procalcitonin and interleukin 8 in the prediction of infected necrosis in acute pancreatitis. Gut 41: 832-840.
5. Muller B, Becker KL, Schochinger H, Rickenbacher PR, Huber PR, Zimmerli W et al (2000) Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit. Crit Care Med 28: 977-983.
6. Ugarte H, Silva E, Mercan D, De Mendonca A, Vincent JL (1999) Procalcitonin used as a marker of infection in the intensive care unit. Crit Care Med 27: 498-504.
7. Picariello C, Lazzeri C, Chiostri M, Gensini GF et al (2009) Procalcitonin in patients with acute coronary syndromes and cardiogenic shock submitted to percutaneous coronary intervention. Intern Emerg Med. doi: 10.1007/s11739-009-0277-9.
8. Kafkas N, Venetsanou K, Patsilinakos S et al (2008) Procalcitonin in acute myocardial infarction. Acute Card Care 10: 30-36.
9. Senturk T, Cordan J, Baran I et al (2007) Procalcitonin in patients with acute coronary syndrome: correlation with high-sensitive C-reactive protein, prognosis and severity of coronary artery disease. Acta Cardiol 62: 135-141.
10. Buratti T, Ricevuti G, Pechlaner C et al (2001) Plasma levels of procalcitonin and interleukin-6 in acute myocardial infarction. Inflammation 25: 97-100.
11. Remskar M, Horvat M, Hojjer S et al (2002) Procalcitonin in patients with acute myocardial infarction. Wien Klin Wochenschr 114: 205-210.
12. Ross R (1999) Atherosclerosis-an inflammatory disease. N Engl J Med 340: 115-126.
13. Liuzzo G, Biasucci LM, Gallimore JR et al (1994) The prognostic value of C-reactive protein and serum amyloid A protein in severe unstable angina. N Engl J Med 331: 417-424.
14. Lindhal B, Toss H, Siegbahn A et al (2000) Markers of myocardial damage and inflammation in relation to long-term mortality in unstable coronary artery disease. N Engl J Med 343: 1139-1147.
15. Brunkhorst FM, Clark AL, Forycki ZF, Anker SD (1999) Pyrexia, procalcitonin, immune activation and survival in cardiogenic shock: the potential importance of bacterial translocation. Int J Cardiol 72: 3-10.
16. Jensen JU, Lundgren B, Hein L, Mohr T, Petersen PL, Andersen LH, Lauritsen AO, Hougaard S, Mantoni T, Bømler B, Thornberg KJ, Thormar K, Løken J, Steensen M, Carl P, Petersen JA, Tousi H, Søe-Jensen P, Bestle M, Hestad S, Andersen MH, Fjeldborg P, Larsen KM, Rossau C, Thomsen CB, Ostergaard C, Kjaer J, Grarup J, Lundgren JD (2008) The Procalcitonin And Survival Study (PASS)-a randomised multi-center investigator-initiated trial to investigate whether daily measurements biomarker procalcitonin and pro-active diagnostic and therapeutic responses to abnormal procalcitonin levels, can improve survival in intensive care unit patients. Calculated sample size (target population): 1000 patients. BMC Infect Dis 8: 91.